295 related articles for article (PubMed ID: 32210956)
1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics.
Kotraiah V; Phares TW; Browne CD; Pannucci J; Mansour M; Noe AR; Tucker KD; Christen JM; Reed C; MacKay A; Weir GM; Rajagopalan R; Stanford MM; Chung CS; Ayala A; Huang J; Tsuji M; Gutierrez GM
Front Immunol; 2020; 11():264. PubMed ID: 32210956
[TBL] [Abstract][Full Text] [Related]
2. A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors.
Tobias J; Battin C; De Sousa Linhares A; Lebens M; Baier K; Ambroz K; Drinić M; Högler S; Inic-Kanada A; Garner-Spitzer E; Preusser M; Kenner L; Kundi M; Zielinski CC; Steinberger P; Wiedermann U
Front Immunol; 2020; 11():895. PubMed ID: 32528470
[TBL] [Abstract][Full Text] [Related]
3. A Peptide-Based PD1 Antagonist Enhances T-Cell Priming and Efficacy of a Prophylactic Malaria Vaccine and Promotes Survival in a Lethal Malaria Model.
Phares TW; Kotraiah V; Karunarathne DS; Huang J; Browne CD; Buontempo P; Mansour M; Noe AR; Wykes MN; Pannucci J; Tsuji M; Gutierrez GM
Front Immunol; 2020; 11():1377. PubMed ID: 32733457
[TBL] [Abstract][Full Text] [Related]
4. TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model.
Castro Eiro MD; Hioki K; Li L; Wilmsen MEP; Kiernan CH; Brouwers-Haspels I; van Meurs M; Zhao M; de Wit H; Grashof DGB; van de Werken HJG; Mueller YM; Schliehe C; Temizoz B; Kobiyama K; Ishii KJ; Katsikis PD
J Immunol; 2024 Feb; 212(3):455-465. PubMed ID: 38063488
[TBL] [Abstract][Full Text] [Related]
5. Oncolytic Newcastle disease virus expressing a checkpoint inhibitor as a radioenhancing agent for murine melanoma.
Vijayakumar G; Palese P; Goff PH
EBioMedicine; 2019 Nov; 49():96-105. PubMed ID: 31676387
[TBL] [Abstract][Full Text] [Related]
6. Immune checkpoint blockade in infectious diseases.
Wykes MN; Lewin SR
Nat Rev Immunol; 2018 Feb; 18(2):91-104. PubMed ID: 28990586
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of PD1/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine.
Albershardt TC; Parsons AJ; Reeves RS; Flynn PA; Campbell DJ; Ter Meulen J; Berglund P
Vaccine; 2020 Apr; 38(17):3369-3377. PubMed ID: 32088020
[TBL] [Abstract][Full Text] [Related]
8. Immunomodulators as adjuvants for vaccines and antimicrobial therapy.
Nicholls EF; Madera L; Hancock RE
Ann N Y Acad Sci; 2010 Dec; 1213():46-61. PubMed ID: 20946578
[TBL] [Abstract][Full Text] [Related]
9. Immunization of patients with melanoma peptide vaccines: immunologic assessment using the ELISPOT assay.
Pass HA; Schwarz SL; Wunderlich JR; Rosenberg SA
Cancer J Sci Am; 1998; 4(5):316-23. PubMed ID: 9815296
[TBL] [Abstract][Full Text] [Related]
10. A Peptide-Based Checkpoint Immunomodulator Alleviates Immune Dysfunction in Murine Polymicrobial Sepsis.
Phares TW; Kotraiah V; Chung CS; Unsinger J; Mazer M; Remy KE; Browne CD; Buontempo P; Mansour M; Pannucci J; Ayala A; Hotchkiss RS; Gutierrez GM
Shock; 2021 Jun; 55(6):806-815. PubMed ID: 33065715
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity and antitumor efficacy of a novel human PD-1 B-cell vaccine (PD1-Vaxx) and combination immunotherapy with dual trastuzumab/pertuzumab-like HER-2 B-cell epitope vaccines (B-Vaxx) in a syngeneic mouse model.
Kaumaya PTP; Guo L; Overholser J; Penichet ML; Bekaii-Saab T
Oncoimmunology; 2020 Oct; 9(1):1818437. PubMed ID: 33117602
[TBL] [Abstract][Full Text] [Related]
12. Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy.
Fromm G; de Silva S; Johannes K; Patel A; Hornblower JC; Schreiber TH
J Immunother Cancer; 2018 Dec; 6(1):149. PubMed ID: 30563566
[TBL] [Abstract][Full Text] [Related]
13. Applications of chemokines as adjuvants for vaccine immunotherapy.
Mohan T; Zhu W; Wang Y; Wang BZ
Immunobiology; 2018; 223(6-7):477-485. PubMed ID: 29246401
[TBL] [Abstract][Full Text] [Related]
14. Injectable polypeptide hydrogel-based co-delivery of vaccine and immune checkpoint inhibitors improves tumor immunotherapy.
Song H; Yang P; Huang P; Zhang C; Kong D; Wang W
Theranostics; 2019; 9(8):2299-2314. PubMed ID: 31149045
[TBL] [Abstract][Full Text] [Related]
15. Sym021, a promising anti-PD1 clinical candidate antibody derived from a new chicken antibody discovery platform.
Gjetting T; Gad M; Fröhlich C; Lindsted T; Melander MC; Bhatia VK; Grandal MM; Dietrich N; Uhlenbrock F; Galler GR; Strandh M; Lantto J; Bouquin T; Horak ID; Kragh M; Pedersen MW; Koefoed K
MAbs; 2019; 11(4):666-680. PubMed ID: 31046547
[TBL] [Abstract][Full Text] [Related]
16. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
[TBL] [Abstract][Full Text] [Related]
17. The basics and advances of immunomodulators and antigen presentation: a key to development of potent memory response against pathogens.
Garai P; Gogoi M; Gopal G; Radhakrishnan Y; Nandakumar KS; Chakravortty D
Expert Opin Biol Ther; 2014 Oct; 14(10):1383-97. PubMed ID: 24897303
[TBL] [Abstract][Full Text] [Related]
18. The long multi-epitope peptide vaccine combined with adjuvants improved the therapeutic effects in a glioblastoma mouse model.
Tran TA; Kim YH; Kim GE; Jung S; Kim IY; Moon KS; Kim YJ; Lee TK; Yun H; Lee JJ; Lee HJ; Lee CW; Jung TY
Front Immunol; 2022; 13():1007285. PubMed ID: 36439089
[TBL] [Abstract][Full Text] [Related]
19. The adjuvant effect of melanin is superior to incomplete Freund's adjuvant in subunit/peptide vaccines in mice.
Cuzzubbo S; Banissi C; Rouchon MS; Tran T; Tanchot C; Tartour E; Carpentier AF
Cancer Immunol Immunother; 2020 Dec; 69(12):2501-2512. PubMed ID: 32561966
[TBL] [Abstract][Full Text] [Related]
20. Immune Profile Analysis in Peripheral Blood and Tumor in Patients with Malignant Melanoma.
Saito R; Sawada Y; Nakamura M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
